However, our current findings reveal a different aspect of FCGR regulation, showing that surface expression of FcyRI and FcyRII is markedly increased on macrophages in SSc patients, with FcγRI being particularly prominent. The gene discussed is FCGR2A; the disease is systemic sclerosis.